✦ LIBER ✦

Long-term safety and efficacy data of taliglucerase alfa, a Plant cell-expressed recombinant glucocerebrosidase, in the treatment of naïve Gaucher disease patients: 36-Month Results

✍ Scribed by Zimran, Ari; Mehta, Atul; Giraldo, Pilar; Rosenbaum, Hanna; Giona, Fiorina; Amato, Dominick J.; Petakov, Milan; Muñoz, Eduardo Terreros; Solorio-Meza, Sergio Eduardo; Durán, Gloria; Elstein, Deborah; Chertkoff, Raul; Brill-Almon, Einat

Book ID: 122401468
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 59 KB
Volume: 108
Category: Article
ISSN: 1096-7192
DOI: 10.1016/j.ymgme.2012.11.280

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long Term Safety and Efficacy Data of Ta

Long Term Safety and Efficacy Data of Taliglucerase Alfa, a Plant Cell Expressed Recombinant Glucocerebrosidase, in Treatment Of Naïve Gaucher Disease Patients

✍ Ari Zimran; Rene Heitner; Atul Mehta; PIlar Giraldo; Hanna Rosenbaum; Florina Gi 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Safety and efficacy of long-term velaglu

Safety and efficacy of long-term velaglucerase alfa therapy in treatment-naïve adults with type 1 Gaucher disease: results from Phase III trials

✍ Giraldo, Pilar; Zimran, Ari; Mehta, Atul; Hughes, Derralynn; Hangartner, Thomas 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 265 KB

A Phase 3, multicenter, open-label, swit

A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with imiglucerase

✍ Pastores, Gregory M.; Petakov, Milan; Giraldo, Pilar; Rosenbaum, Hanna; Szer, Je 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 614 KB